![](images/null.gif) |
![](images/null.gif) |
![](images/null.gif) |
|
Impact of Rheumatologic Therapies on Cardiovascular Outcomes in People with HIV
|
|
|
RD was significantly associated with CVD events (OR = 2.67; p<0.001). 660 CVD events were observed including: myocardial infarction 264 (40%), stroke 110 (16.66%), heart failure 180 (27.27%) and peripheral arterial disease 160 (16.06%).
Compared to the no medication group, exposure to multiple medications (HR=2.121, p=0.047), NSAIDs (HR=1.694, p=0.003), steroids (HR=2.332 p<0.0001), or hypouricemic agents and colchicine (HR=3.445, p<0.0001) were significantly associated with CVD events after adjusting for covariates.
Efficacy and Safety of Low-Dose Colchicine after Myocardial
Infarction
Could Colchicine Be the New Aspirin?
CROI 2022 Feb 11-16
Boghuma K. Titanji, Shumpei Nagatomi, Julia Gallini , Xianqing Cui, Vincent C. Marconi Emory University School of Medicine, Atlanta, Georgia, United Sates of America
![0223221](../images/022422/022422-11/0223221.gif)
![0223222](../images/022422/022422-11/0223222.gif)
![0223223](../images/022422/022422-11/0223223.gif)
![0223224](../images/022422/022422-11/0223224.gif)
![0223225](../images/022422/022422-11/0223225.gif)
|
|
|
![](images/null.gif) |
![](images/null.gif) |
|
|